[VIEW] agent=VP, Theatrical Distribution | scenario_id=73 | rounds=20

--- Round 0 ---
[R0.1] VP, Theatrical Distribution (speak, public): Given the competitive release pressure with a major competitor opening on July 25, 2026, we need to consider how moving our release date three weeks later will impact our opening weekend, which our internal model suggests could reduce by 8%. How do we feel about the potential audience demand and the flexibility in our paid media strategy? I also want to ensure that we preserve our premium format access without any operational surprises. Can we validate our current commitments and any potential contractual tripwires that might affect this plan?
[R0.2] Director, Marketing Insights (speak, public): I believe we should review our current domestic awareness tracking and trailer engagement metrics to gauge audience demand more accurately. Our unaided awareness is at 32% among the 13–34 demographic, which indicates a solid base for potential interest. Additionally, our trailer achieved 18 million views in the first week with a 41% completion rate, suggesting strong engagement. We should also assess the flexibility of reallocating our $4 million within the paid media commitments to support the new timing, while ensuring we maintain our premium format access. Can we discuss any contractual constraints that might affect these adjustments?
[R0.3] Business Affairs Counsel (speak, public): I appreciate the insights on audience demand and engagement metrics. Regarding the contractual constraints, we need to ensure we comply with the talent approval notice, which requires a 10 business day notice period for any changes. Additionally, we should consider the PLF exclusivity of 21 days and the screen-count floor of 350 to avoid any potential legal exposure. Let's evaluate our options based on these parameters before making any decisions.

--- Round 1 ---
[R1.1] VP, Theatrical Distribution (speak, private to=Director, Marketing Insights,Business Affairs Counsel): Thank you for the insights on audience demand and contractual constraints. Given our current domestic booking status, with 3,850 screens tentatively held, and the need to avoid any operational surprises, I propose we have a dedicated session to map out the implications of moving our release date and ensure that we can meet our minimum guarantees without risking the PLF exclusivity window. I’d like to hear your thoughts on how we can structure this session effectively.
[R1.2] Director, Marketing Insights (speak, public): I agree that a dedicated session would be beneficial to thoroughly assess the implications of the proposed release date shift. We can analyze the audience demand metrics alongside the contractual constraints to ensure we are making an informed decision. Let's outline the key points we need to cover in that session to maximize our time effectively.
[R1.3] Business Affairs Counsel (speak, private to=VP, Theatrical Distribution,Director, Marketing Insights): I agree that a dedicated session is crucial. To structure it effectively, we should outline the specific legal implications of the proposed date shift, such as the talent approval timeline and the PLF commitments. We should also identify any potential hidden revenue guarantees or exit fees that might influence our decision. Let's set a time for this session and make sure we have all relevant data ready for discussion.

--- Round 2 ---
[R2.1] VP, Theatrical Distribution (speak, private to=Director, Marketing Insights,Business Affairs Counsel): Let's schedule our dedicated session to discuss the implications of the proposed date shift. I suggest we review the audience demand metrics alongside the contractual constraints and outline any potential legal implications, particularly regarding the talent approval timeline and PLF commitments. How does next week look for everyone?
[R2.2] Director, Marketing Insights (speak, private to=VP, Theatrical Distribution,Business Affairs Counsel): I think next week works well for our session. I’ll prepare the latest audience demand metrics and ensure we have a clear outline of the contractual constraints to discuss. Let's confirm a specific time.
[R2.3] Business Affairs Counsel (leave, public): 

--- Round 3 ---
[R3.1] VP, Theatrical Distribution (leave, public): 
[R3.2] Director, Marketing Insights (leave, public): 
[R3.3] Business Affairs Counsel (leave, public): 

--- Round 4 ---
[R4.1] VP, Theatrical Distribution (leave, public): 
[R4.2] Director, Marketing Insights (leave, public): 
[R4.3] Business Affairs Counsel (leave, public): 

--- Round 5 ---
[R5.1] VP, Theatrical Distribution (leave, public): 
[R5.2] Director, Marketing Insights (leave, public): 
[R5.3] Business Affairs Counsel (leave, public): 

--- Round 6 ---
[R6.1] VP, Theatrical Distribution (leave, public): 
[R6.2] Director, Marketing Insights (leave, public): 
[R6.3] Business Affairs Counsel (leave, public): 

--- Round 7 ---
[R7.1] VP, Theatrical Distribution (leave, public): 
[R7.2] Director, Marketing Insights (leave, public): 
[R7.3] Business Affairs Counsel (leave, public): 

--- Round 8 ---
[R8.1] VP, Theatrical Distribution (leave, public): 
[R8.2] Director, Marketing Insights (leave, public): 
[R8.3] Business Affairs Counsel (leave, public): 

--- Round 9 ---
[R9.1] VP, Theatrical Distribution (leave, public): 
[R9.2] Director, Marketing Insights (leave, public): 
[R9.3] Business Affairs Counsel (leave, public): 

--- Round 10 ---
[R10.1] VP, Theatrical Distribution (leave, public): 
[R10.2] Director, Marketing Insights (leave, public): 
[R10.3] Business Affairs Counsel (leave, public): 

--- Round 11 ---
[R11.1] VP, Theatrical Distribution (leave, public): 
[R11.2] Director, Marketing Insights (leave, public): 
[R11.3] Business Affairs Counsel (leave, public): 

--- Round 12 ---
[R12.1] VP, Theatrical Distribution (leave, public): 
[R12.2] Director, Marketing Insights (leave, public): 
[R12.3] Business Affairs Counsel (leave, public): 

--- Round 13 ---
[R13.1] VP, Theatrical Distribution (leave, public): 
[R13.2] Director, Marketing Insights (leave, public): 
[R13.3] Business Affairs Counsel (leave, public): 

--- Round 14 ---
[R14.1] VP, Theatrical Distribution (leave, public): 
[R14.2] Director, Marketing Insights (leave, public): 
[R14.3] Business Affairs Counsel (leave, public): 

--- Round 15 ---
[R15.1] VP, Theatrical Distribution (leave, public): 
[R15.2] Director, Marketing Insights (leave, public): 
[R15.3] Business Affairs Counsel (leave, public): 

--- Round 16 ---
[R16.1] VP, Theatrical Distribution (leave, public): 
[R16.2] Director, Marketing Insights (leave, public): 
[R16.3] Business Affairs Counsel (leave, public): 

--- Round 17 ---
[R17.1] VP, Theatrical Distribution (leave, public): 
[R17.2] Director, Marketing Insights (leave, public): 
[R17.3] Business Affairs Counsel (leave, public): 

--- Round 18 ---
[R18.1] VP, Theatrical Distribution (leave, public): 
[R18.2] Director, Marketing Insights (leave, public): 
[R18.3] Business Affairs Counsel (leave, public): 

--- Round 19 ---
[R19.1] VP, Theatrical Distribution (leave, public): 
[R19.2] Director, Marketing Insights (leave, public): 
[R19.3] Business Affairs Counsel (leave, public): 

